Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | REGN | GSK | ARGX | ||
| Company | Regeneron Pharmaceuticals | Gsk Plc ADR | Argenx Se ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 670.06 | 52.98 | 904.79 | ||
| High | 676.66 | 53.06 | 904.79 | ||
| Low | 658.50 | 52.31 | 868.54 | ||
| Latest | 664.52 | 52.78 | 877.62 | ||
| Change | -3.43 | +0.31 | -31.87 | ||
| % Change | -0.51% | +0.59% | -3.50% | ||
| Volume | 581,700 | 2,867,600 | 325,000 | ||
| 20-Day Average Volume | 1,022,945 | 3,675,055 | 384,000 | ||
| Previous Close | 667.95 | 52.47 | 909.49 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 631.70 | 52.29 | 896.96 | ||
| 20-Day Raw Stochastic | 83.86% | 60.88% | 34.43% | ||
| 20-Day Relative Strength | 54.55 | 52.37 | 51.19 | ||
| Weighted Alpha | +9.69 | +30.91 | +45.83 | ||
| Today's Opinion | 40% Sell | 24% Buy | 72% Buy | ||
| Previous Opinion | 40% Sell | 24% Buy | 88% Buy | ||
| Last Month's Opinion | 72% Sell | 8% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.57% since 07/02/26 | -1.64% since 07/02/26 | -6.60% since 07/02/26 | ||
| Low | 637.72 on 07/06/26 | 52.29 on 07/09/26 | 868.54 on 07/10/26 | ||
| High | 677.92 on 07/07/26 | 54.29 on 07/07/26 | 940.26 on 07/06/26 | ||
| 1-Month | |||||
| %Chg | +10.45% since 06/10/26 | +3.15% since 06/10/26 | +1.79% since 06/10/26 | ||
| Low | 594.90 on 06/22/26 | 50.43 on 06/18/26 | 837.74 on 06/24/26 | ||
| High | 677.92 on 07/07/26 | 54.29 on 07/07/26 | 953.58 on 07/02/26 | ||
| 3-Month | |||||
| %Chg | -11.26% since 04/10/26 | -9.33% since 04/10/26 | +9.75% since 04/10/26 | ||
| Low | 591.52 on 06/02/26 | 48.57 on 06/02/26 | 754.84 on 04/29/26 | ||
| High | 767.21 on 04/23/26 | 59.57 on 04/14/26 | 953.58 on 07/02/26 | ||
| 6-Month | |||||
| %Chg | -16.58% since 01/09/26 | +4.74% since 01/09/26 | +11.30% since 01/09/26 | ||
| Low | 591.52 on 06/02/26 | 47.62 on 01/20/26 | 661.85 on 03/20/26 | ||
| High | 815.00 on 02/17/26 | 61.69 on 02/18/26 | 953.58 on 07/02/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 70,253,056 | 106,886,256 | 54,577,420 | ||
| Shares Outstanding, K | 105,720 | 2,025,128 | 62,188 | ||
| Annual Sales | 14,342,900,000 | 43,077,970,000 | 4,248,050,000 | ||
| Annual Net Income | 4,504,900,000 | 7,537,690,000 | 1,292,040,000 | ||
| Last Quarter Sales | 3,605,400,000 | 10,280,080,000 | 1,313,000,000 | ||
| Last Quarter Net Income | 727,200,000 | 2,340,610,000 | 366,000,000 | ||
| 60-Month Beta | 0.24 | 0.35 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 9.47 on 04/29/26 | 1.24 on 04/29/26 | 5.52 on 05/07/26 | ||
| Earnings Date | 07/30/26 | 07/28/26 | 07/30/26 | ||
| Most Recent Dividend | 0.940 on 05/20/26 | 0.447 on 05/15/26 | N/A | ||
| Next Ex-Dividends Date | 05/20/26 | 05/15/26 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 17.98 | 11.33 | 40.49 | ||